Author
Hannes Alber
Also Known As
Alber, Hannes F, Andreas Schober, Annette Prim, Frank Ruschitzka, H ALBER, H Alber, H F Alber, H. Alber, H. F. Alber, H.F. Alber
160
Publications
4K
Citations
34
H-Index
87
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 20 | 29 | 1.2K |
2 | Public Health | 13 | 13 | 778 |
3 | Health Sciences | 7 | 7 | 441 |
4 | Applied Physiology | 2 | 2 | 60 |
5 | Engineering | 1 | 1 | 40 |
Hannes Alber
×
57
Publications
3.6K
Citations
33
H-Index
| Year | Citations | |
|---|---|---|
2003 | 339 | |
2010 | 266 | |
2022 | 266 | |
2006 | 167 | |
2022 | 142 | |
2011 | 129 | |
2005 | 110 | |
2008 | 102 | |
2011 | 101 | |
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial Axel Bauer, Michael Schreinlechner, Nikolay Sappler, The Lancet Respiratory Medicine Open-label TrialHypertensionCardiovascular DiseaseAntihypertensive TherapyClinical Trials | 2021 | 101 |
Page 1
Page 1